HCA - HCA Healthcare, Inc.
NEXT EARNINGS:
Apr 24, 2026
EPS Est: $7.17
|
Rev Est: $19.1B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$523.92
DETAILS
HIGH:
$635.00
LOW:
$425.00
MEDIAN:
$525.00
CONSENSUS:
$523.92
DOWNSIDE:
0.49%
Market Cap:
117.74B
Volume:
1,234,722
Avg Volume:
1,193,836
52 Week Range:
295-552.9
Sector:
Healthcare
Industry:
Medical - Care Facilities
Beta:
1.36
Last Dividend:
$2.88
Exchange:
NYSE
Country:
US
Employees:
226,000
IPO Date:
2011-03-10
EPS (TTM):
28.62
P/E Ratio:
15.88
Revenue (TTM):
75.60B
Total Assets:
60.72B
Total Debt:
50.20B
Cash & Equiv:
1.04B
Rev Growth (5Y):
8.0%
EPS Growth (5Y):
20.9%
FCF Growth (5Y):
3.8%
ROCE:
27.2%
Debt/Equity:
-8.33
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-27 | $8.01 | $7.46 | +7.4% | $19.5B | $19.7B | -0.9% |
| 2025-10-24 | $6.96 | $5.79 | +20.2% | $19.2B | $18.6B | +3.0% |
| 2025-07-25 | $6.84 | $6.29 | +8.7% | $18.6B | $18.5B | +0.6% |
| 2025-04-25 | $6.45 | $5.75 | +12.2% | $18.3B | $18.3B | +0.3% |
| 2025-01-24 | $6.22 | $6.13 | +1.5% | $18.3B | $18.2B | +0.3% |
| 2024-10-25 | $5.03 | $4.99 | +0.8% | $17.5B | $17.5B | -0.3% |
| 2024-07-23 | $5.53 | $4.85 | +14.0% | $17.5B | $17.1B | +2.6% |
| 2024-04-26 | $5.93 | $5.01 | +18.4% | $17.3B | $16.8B | +3.1% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 75.60B | 70.60B | 64.97B | 60.23B | 58.75B | 51.53B | 51.34B | 46.68B | 43.61B | 41.49B | 39.68B | 36.92B |
| Net Income | 6.78B | 5.76B | 5.24B | 5.64B | 6.96B | 3.75B | 3.50B | 3.79B | 2.22B | 2.89B | 2.13B | 1.88B |
| EPS | 28.62 | 22.27 | 19.24 | 19.44 | 21.51 | 11.10 | 10.27 | 11.04 | 6.33 | 7.80 | 5.34 | 4.46 |
| Total Assets | 60.72B | 59.51B | 56.21B | 52.44B | 50.74B | 47.49B | 45.06B | 39.21B | 36.59B | 33.76B | 32.74B | 31.20B |
| Total Debt | 50.20B | 45.24B | 41.86B | 40.20B | 36.73B | 33.06B | 35.57B | 32.82B | 33.06B | 31.38B | 30.49B | 29.43B |
| Cash & Equivalents | 1.04B | 1.93B | 935.00M | 908.00M | 1.45B | 1.79B | 621.00M | 502.00M | 732.00M | 646.00M | 741.00M | 566.00M |
| Operating Cash Flow | 12.64B | 10.51B | 9.43B | 8.52B | 8.96B | 9.23B | 7.60B | 6.76B | 5.43B | 5.65B | 4.73B | 4.45B |
| Free Cash Flow | 7.69B | 5.64B | 4.69B | 4.13B | 5.38B | 6.40B | 3.44B | 3.19B | 2.41B | 2.89B | 2.36B | 2.27B |
| FCF per Share | 33.34 | 21.81 | 17.21 | 14.21 | 16.65 | 18.91 | 10.09 | 9.30 | 6.89 | 7.81 | 5.92 | 5.40 |
| Book Value | (6.03B) | (2.50B) | (1.77B) | (2.77B) | (933.00M) | 572.00M | (2.81B) | (4.95B) | (6.81B) | (7.30B) | (7.60B) | (7.89B) |
| Cash & ST Investments | 1.04B | 2.02B | 935.00M | 908.00M | 1.45B | 1.79B | 621.00M | 502.00M | 732.00M | 646.00M | 741.00M | 566.00M |
| ROC Equity | N/A | N/A | N/A | N/A | N/A | 6.56 | N/A | N/A | N/A | N/A | N/A | N/A |